Summit Partners Public Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-75,000
Closed -$15.8M 171
2024
Q3
$15.8M Buy
+75,000
New +$13M 0.49% 61
2023
Q4
Sell
-40,000
Closed -$7.94M 164
2023
Q3
$7.94M Buy
+40,000
New +$10.1M 0.35% 87
2022
Q4
Sell
-73,000
Closed -$12.9M 107
2022
Q3
$12.9M Buy
73,000
+33,000
+83% +$6.63M 0.67% 49
2022
Q2
$7.31M Buy
+40,000
New +$7.98M 0.33% 75
2020
Q1
Sell
-50,000
Closed -$3.71M 92
2019
Q4
$3.71M Buy
+50,000
New +$3.21M 0.35% 63

Other funds holding INSP

Summit Partners Public Asset Management's INSP Position: Q1 2024 in Review

Summit Partners Public Asset Management sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 141,777 shares — an estimated $28.8M sold.

Summit Partners Public Asset Management first reported a position in INSP in Q2 2018 and held it in 15 quarters. The position peaked at $91.6M in Q2 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Summit Partners Public Asset Management reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 141,777 Inspire Medical Systems shares in Q1 2024, an estimated $28.8M.
  • Summit Partners Public Asset Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 15 quarters.
  • Summit Partners Public Asset Management's Inspire Medical Systems position peaked at $91.6M in Q2 2023.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2024, filed 15 May 2024.